![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
DISEASE OUTCOMES AFTER DAA-INDUCED SVR:
DATA FROM THE RESIST-HCV COHORT
|
|
|
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Vincenza Calvaruso*, S. Pe'a, I. Cacciola, G. Cabibbo, F. Cartabello'a, A. Di Rosolini, A. Davi`, M. Cannavo`, M. Russello, M. Distefano, G. Scifo, F. Di Lorenzo, T. PresBleo, L. Larocca, A. MonBneri, G. Fuduli, A. Digiacomo, M. Cannizzaro, S. Madonia, A. Licata, G. Malizia, G. Alaimo, G. BerBno, B.
Cacopardo, C. Iacobello, A. Averna, L. Guarneri, I. Scalisi, G. Mazzola, L. Mondello, V. Portelli, G. Squadrito, C. Camma`, G. Raimondo , A. Craxi`, V. Di Marco on behalf of RESIST-HCV
![0417181](../images%20/041718/041718-10/0417181.gif)
![0417182](../images%20/041718/041718-10/0417182.gif)
![0417183](../images%20/041718/041718-10/0417183.gif)
![0417184](../images%20/041718/041718-10/0417184.gif)
![0417185](../images%20/041718/041718-10/0417185.gif)
![0417186](../images%20/041718/041718-10/0417186.gif)
![0417187](../images%20/041718/041718-10/0417187.gif)
![0417188](../images%20/041718/041718-10/0417188.gif)
![0417189](../images%20/041718/041718-10/0417189.gif)
![04171810](../images%20/041718/041718-10/04171810.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|